• Slice of Finance
  • Posts
  • Grant Thornton Welcomes Krystn Hammond as CFO Advisory Principal

Grant Thornton Welcomes Krystn Hammond as CFO Advisory Principal

Author

Slice of Finance Team
17 Jul

Key Highlights:

  • Krystn Hammond joins Grant Thornton as CFO Advisory principal.

  • Over 15 years of experience in pharmaceutical and life sciences advisory.

  • Focus on valuation solutions and strategic decision-making for life sciences clients.

Source (Business Wire)

Notable Quotes:

❝

“From advising on transactions to providing solutions across all life sciences subsectors, Krystn brings more than a decade of knowledge and skill to Grant Thornton’s CFO Advisory practice. Her extensive experience helping organizations make strategic and thoughtful decisions will provide immense value for our firm and the clients we serve.”

Paul Melville, National Managing Principal of CFO Advisory at Grant Thornton Advisors LLC
❝

“The life sciences industry is constantly evolving, and our clients deserve quality-driven solutions that provide value to their businesses. Krystn's wealth of life sciences knowledge will help strengthen our industry offerings and provide our clients with tailored services that meet their unique needs.”

Zara Muradali, National Life Sciences Leader at Grant Thornton Advisors LLC
❝

“I’m grateful to be part of a firm that sets exemplary standards in everything from client service to company culture. I look forward to working with a team of dynamic valuation professionals to help our life sciences clients make well-informed strategic decisions to add value to both patients and shareholders.”

Krystn Hammond, CFO Advisory Principal at Grant Thornton

Our Take:

Grant Thornton's strategic addition of Krystn Hammond as a CFO Advisory principal underscores the firm's commitment to strengthening its advisory capabilities within the life sciences sector. Hammond's extensive background, spanning transactions and tax restructurings for high-profile pharmaceutical and biotech clients, aligns seamlessly with Grant Thornton's mission to provide industry-specific, value-driven solutions. Her role will undoubtedly enhance the firm's ability to deliver comprehensive valuation services, helping clients navigate the complexities of the ever-evolving life sciences landscape. This move reflects Grant Thornton’s proactive approach to meeting the unique needs of its clients with specialized expertise and strategic insight.